• Corpus ID: 6104912

How to design multi-target drugs: Target search options in cellular networks

  title={How to design multi-target drugs: Target search options in cellular networks},
  author={Tam{\'a}s Korcsm{\'a}ros and Mate S. Szalay and Csaba Bode and Istv{\'a}n A. Kov{\'a}cs and P{\'e}ter Csermely},
  journal={arXiv: Molecular Networks},
Despite improved rational drug design and a remarkable progress in genomic, proteomic and high-throughput screening methods, the number of novel, single-target drugs fell much behind expectations during the past decade. Multi-target drugs multiply the number of pharmacologically relevant target molecules by introducing a set of indirect, network-dependent effects. Parallel with this the low-affinity binding of multi-target drugs eases the constraints of druggability, and significantly increases… 

Figures and Tables from this paper

Network pharmacology: the next paradigm in drug discovery.

A new appreciation of the role of polypharmacology has significant implications for tackling the two major sources of attrition in drug development--efficacy and toxicity.

System-level multi-target drug discovery from natural products with applications to cardiovascular diseases

It is found that four of the five randomly selected natural molecules can effectively act on the target set for CVDs, indicating the reasonability of the systems-based method.

Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.

A global view on polypharmacology is provided, which is the foundation of the next paradigm in drug discovery, and some computational methods to predict the potential novel multi-target drugs with lower toxicity and higher efficacy are presented.

Network based approach to drug discovery: a mini review.

This work reviews how different types of network analysis approaches facilitate drug discovery and their associated challenges and shows that network analysis is a powerful, integrated, computational and experimental approach to improve the drug discovery process.

Finding multiple target optimal intervention in disease-related molecular network

A robust computational algorithm for finding multiple target optimal intervention (MTOI) solutions in a disease network and suggests optimal combinations of the target intervention that best restore the network to a normal state, which can be customer designed.

Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.

Efforts to employ in silico methods for facilitating the search and design of selective multi-target agents have shown promising potential in facilitating drug discovery directed at selective multiple targets and is expected to contribute to intelligent lead anticancer drugs.

De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy

This paper reports the first de novo multitarget ligand design method, with an iterative fragment-growing strategy, generally applicable in rational and efficient multitarget drug design, especially for the design of highly integrated inhibitors for proteins with dissimilar binding pockets.

[Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases].

The paper outlines the concept of the multi-target-directed ligand design and examples of its use in the search of a cure for AD, and provides numerous examples of compounds which proved in in vitro tests to be multifunctional ligands.

What is next for small-molecule drug discovery?

In recent years, several alternative strategies have appeared in the form of the emerging paradigms of polypharmacology, systems biology and personalized medicine, which point to key challenges and breakthroughs likely to affect the future of small-molecule drug discovery.



The efficiency of multi-target drugs: the network approach might help drug design.

How many drug targets are there?

A consensus number of current drug targets for all classes of approved therapeutic drugs is proposed, and an emerging realization of the importance of polypharmacology and also the power of a gene-family-led approach in generating novel and important therapies is highlighted.

Rational drug design via intrinsically disordered protein.

Protein-interaction mapping in search of effective drug targets.

Challenges and breakthroughs in protein-interaction mapping reveal relationships between proteins and their impact on cellular processes and is being used more widely in the understanding of disease mechanisms and their treatment.

A robustness-based approach to systems-oriented drug design

  • H. Kitano
  • Biology
    Nature Reviews Drug Discovery
  • 2007
This work uses examples that are based on existing drugs to illustrate the concept of robustness, and discusses how a greater consideration of the importance of robustity could influence the design of new drugs that will be intended to control complex systems.

Strategies for optimizing combinations of molecularly targeted anticancer agents

Issues that pose challenges to the rational preclinical and clinical evaluation of such combinations will be described, and possible approaches to overcoming these challenges will be discussed.